CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Philips ushers new era in radiology science with Imaging 2.0 technology at RSNA annual meeting

This year at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.

From Philips Healthcare 29 Nov 2010

Philips Electronics showcases first-ever digital broadband MRI solution at RSNA annual meeting

Today at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics showcased Philips Ingenia, the first-ever digital broadband magnetic resonance imaging (MRI) solution.

29 Nov 2010

Toshiba launches Volume Navigation 3D roadmapping for InfinixTM-i vascular X-ray product line

During complex interventional procedures, it is challenging to accurately navigate and interpret the vascular anatomy for precise device deployment. To aid physicians during such interventions, Toshiba America Medical Systems, Inc., has introduced Volume Navigation 3D roadmapping for the InfinixTM-i vascular X-ray product line, providing greater confidence during difficult interventional procedures.

24 Nov 2010

Two surveys show 'huge variation' in health costs in U.S.

The Wall Street Journal: Two studies out Monday - one is a country-by-country survey by the International Federation of Health Plans, and the second from Change: healthcare - "attempt to bring some clarity to how costs stack up, both between different countries and among U.S. providers that might be just a few blocks apart."

24 Nov 2010

Health law repeal murky as groups press officials, target specific provisions

In an analysis, The New York Times, reports that while "Republicans have a big majority in the House, Democratic control of the Senate and the presidential veto power make repeal [of the health law] or major change impossible. [But] there is another reason. More than a few Republicans know that while the politics of trying to nitpick provisions and curb funding are appealing, any wholesale repeal of major provisions of the health care overhaul is likely to generate a backlash.

23 Nov 2010

First Global Symposium on Health Systems Research kicks off in Switzerland

The First Global Symposium on Health Systems Research bringing together researchers, policymakers and donors kicked off in Montreux, Switzerland, on Tuesday, with some conference attendees calling for African leaders to do more to promote health progress in their countries, PANA/Afrique en ligne reports.

18 Nov 2010

Republicans take hard line, look for Democrat health law repeal allies

Republicans aren't softening their tough criticism of the health law even as they seek Democratic allies to join them in their bid to repeal the overhaul.

15 Nov 2010

News stories about cancer contain language that contribute to public uncertainty

New research from North Carolina State University shows that most online news stories about cancer contain language that likely contributes to public uncertainty about the disease a significant finding, given that at least one-third of Americans seek health information online.

11 Nov 2010

How much did health care votes cause democratic defeats?

In the end, it may have mattered less whether vulnerable Democratic incumbents voted for or against the health care law than that they simply had a D by their names, The New York Times reports.

8 Nov 2010

Elekta presents solutions for ultimate precision in cancer care at ASTRO Meeting

Elekta presented solutions for ultimate precision in cancer care at an Investor Meeting in conjunction with the 52nd annual American Society for Radiation Oncology (ASTRO) Meeting, in San Diego. Elekta also discussed the market drivers in established and emerging markets, and explained its strategy for sustainable profitable growth.

From Elekta 2 Nov 2010

EMA issues Scientific Advice to Genta's clinical development plan for tesetaxel in patients with gastric cancer

Genta Incorporated today announced that the Company has received Scientific Advice from the European Medicines Agency (EMA) on the Company's clinical development plan for tesetaxel in patients with advanced gastric cancer, which includes a pivotal, randomized, controlled, Phase 3 trial.

2 Nov 2010

GE Healthcare enters agreement to acquire assets of Orbotech Medical

GE Healthcare, a unit of General Electric Company announced that it has entered into an agreement to acquire the assets of Orbotech Medical Solutions Ltd., a subsidiary of Orbotech Ltd. (Orbotech), and a manufacturer of cadmium zinc telluride (CZT) detectors used in GE Healthcare's innovative Alcyone nuclear medicine technology.

1 Nov 2010

Tenofovir gel to prevent HIV transmission nearing approval

Anti HIV drug Tenofovir in its gel form is to be fast-tracked for approval by the US FDA. The announcement was made by Conrad, a nonprofit scientific organization based in Arlington, Virginia that works with reproductive health.

28 Oct 2010

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Verathon Inc. is pleased to introduce the GlideScope Direct intubation trainer, designed to facilitate instruction of classic direct laryngoscopy.

28 Oct 2010

Two-thirds of fetuses with HLHS have strong chance of survival

When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis. In HLHS, one of the heart's pumping chambers is severely underdeveloped. However, say researchers, in two-thirds of cases, reconstructive surgery affords the infant an excellent chance of early survival.

27 Oct 2010

CHI releases new white paper on 510(k) review process

California Healthcare Institute today announced the release of a new white paper titled "Upcoming Changes to the 510(k) Process: New Approval Pathways and the Impact on Medical Device Development and Innovation." CHI is a non-profit public policy research and advocacy organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

27 Oct 2010

New Australian start-up venture could lead to a revolution in personalized medicine

Pharmaceuticals that seek out cancerous cells and deliver treatments to them; imaging techniques that can help doctors detect diseases before the physical signs begin to appear; and medicines that are tailor-made for individual patients, are within the sights of an exciting new Australian start-up venture.

27 Oct 2010

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.

26 Oct 2010

Dual antiplatelet therapy study expanded into Australia and New Zealand

The Harvard Clinical Research Institute (HCRI) announced today that the DAPT Study has expanded into Australia and New Zealand. Professor Ian Meredith, MBBS, Ph.D., interventional cardiologist at MonashHeart in Melbourne, Australia and National Coordinating Investigator for the DAPT Study in Australia, was the first Pacific Rim investigator to enroll patients into the study.

26 Oct 2010

Canon to showcase imageFORMULA document scanning portfolio at MGMA Annual Conference

Reflecting the increased need for medical practices and healthcare facilities to streamline patient record processes in order to increase efficiency across a range of insurance and billing functions, Canon U.S.A., Inc., a leader in digital imaging, will showcase an array of workflow simplifying solutions from its innovative imageFORMULA document scanning portfolio, including the new ScanFront 300P network scanner, at the Medical Group Management Association (MGMA) 2010 Annual Conference, October 24-27, 2010 at the Ernest N. Morial Convention Center in New Orleans.

25 Oct 2010

CLARITY News and Research

Further Reading

Philips ushers new era in radiology science with Imaging 2.0 technology at RSNA annual meeting

Philips Electronics showcases first-ever digital broadband MRI solution at RSNA annual meeting

Toshiba launches Volume Navigation 3D roadmapping for InfinixTM-i vascular X-ray product line

Two surveys show 'huge variation' in health costs in U.S.

Health law repeal murky as groups press officials, target specific provisions

First Global Symposium on Health Systems Research kicks off in Switzerland

Republicans take hard line, look for Democrat health law repeal allies

News stories about cancer contain language that contribute to public uncertainty

How much did health care votes cause democratic defeats?

Elekta presents solutions for ultimate precision in cancer care at ASTRO Meeting

EMA issues Scientific Advice to Genta's clinical development plan for tesetaxel in patients with gastric cancer

GE Healthcare enters agreement to acquire assets of Orbotech Medical

Tenofovir gel to prevent HIV transmission nearing approval

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Two-thirds of fetuses with HLHS have strong chance of survival

CHI releases new white paper on 510(k) review process

New Australian start-up venture could lead to a revolution in personalized medicine

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Dual antiplatelet therapy study expanded into Australia and New Zealand

Canon to showcase imageFORMULA document scanning portfolio at MGMA Annual Conference

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News